The Complexity of Drug Pricing: Analyzing Trump’s Latest Pharmaceutical Initiatives
Since the commencement of his second term, President Donald Trump has implemented a series of aggressive policy initiatives aimed at curbing pharmaceutical costs across the United States. While these executive actions were designed to provide immediate financial relief to consumers, data from the first fiscal quarter reveals a fragmented landscape: select high-profile medications have seen…
